authors
-
Andrzej Borkowski
- Katedra i Klinika Urologii A.M. w Warszawie
Kierownik Kliniki: prof. dr hab. med. Andrzej Borkowski
keywords
-
advanced prostate cancer treatment prognosis
references
- (1) Andersson /.: Estrogens and estramustine phosphate. W monografii: The medical
- management of prostate cancer. L. Denis edit. Springer, 1988, str. 37.
- (2) Botto H., Richard F., Mathieu K, De MouzonJ.: Randomised multicenter trial: Trip-
- torelin vs surgical castration, long term results and Prognostic factors. Proceedings
- of 4th international Symposium on recent advances in urological cancer diagnosis
- and treatment. Paris 1994. S.C.I. edit., str. 307.
- (3) Byar D.P.: The Veterans Administration cooperative urological research group's
- studies on cancer of the prostate. Cancer. 1973, 32, 1126.
- (4) Coffey D.S.: Prostate cancer: An overview of an increasing dilemma. Cancer. 1993,
- 71, 880.
- (5) Denis L., Mahler C: Le traitement du cancer prostatique. Cours superieur franco-
- phone de cancerologie European School of Urology. Edit. I.CI. Montligeon 1991
- str. 119.
- (6) Fourcade R. O.: Is it still justified to withold hormonal treatment until symptoms
- are bothersome? Proceedings of 4th international Symposium on recent advances in
- urological cancer diagnosis and treatment. Paris 1994, S.C.I. edit., str. 133.
- (7) Makler C; Is disease tlare a problem? Cancer Suppl., 1993, 72, 3799.
- (8) Oosterhof C.O.N., Debruyne F.M.J.: Les analogues de la LHRH. Memoires de Co-
- urs superieur francophone de cancerologie European School of Urology. Edit. I.CI.
- Montligeon 1991, str. 73.
- (9) Pontes J.E.: New approaches to the treatment of hormonally unresponsive prostate
- cancer. A review. Proceedings of 4th international Symposium on recent advances
- in urological cancer diagnosis and treatment. S. C. I. edit., Paris, 1994, str. 368.
-
- (10) Ruutu M, Aro J., Rannikko S.\ High dose polyestradiol fosfate versus orchiectomy
- for prostatic cancer patients with high or low endogenous estradiol. Proceedings of
- 4th international Symposium on recent advances in urological cancer diagnosis and
- treatment. Paris, 1994, S. C. 1. edit., str. 340.
- (11) Sehroder RH.: Adjuyant endocrine treatment of prostatic cancer. European Urolo-
- gy Update Series. EBU edit., 1993, 2, 24.
- (12) Smith RH.: Controversial topics in prostatic cancer. Urol. Pol., 1994, 47, 4.
- (13) Steg A., Zerbib M., ConquvS.: Les estrogens ont-ils encore une place dans le traite-
- ment du cancer de la prostate. Cours superiere francophone de cancerologie Euro-
- pean School of Urology. Montligeon, 1991, I. C. I. edit., str. 69.
- (14) Stege R., Henriksson R, Pousette A., Carlstrom K.: Estradurin, a high dose i.m.
- depot estrogen for safe first line treatment on advanced prostatic cancer. Procee-
- dings of 4th international Symposium on recent advances in urological cancer dia-
- gnosis and treatment. Paris, 1994, S. C. I. edit., str. 343.
- (15) YACURG: Carcinoma of the prostate: treatment comparisons. J. Urol., 1967, 98,
- 516.
|